13F Holdings
中文EN

BAK BRASKEM SA IFRS

Industrial Organic Chemicals · NYSE · SEC CIK 1071438 · Reporting currency BRL · Fiscal year ends 12/31

Financial factors as of 2023-12-31 (FY2023), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-26.9%
TTM net income YoY-1,262.8%
TTM EPS YoY—
Revenue 3-yr CAGR6.4%
Net income 3-yr CAGR—

Margins

Gross margin4.3%
Operating margin-4.0%
Net margin-6.5%
FCF margin-9.6%
EBITDA margin3.4%

Returns

ROE-80.9%
ROA-5.1%
ROIC (approx.)-5.5%
Asset turnover0.79x

Leverage & solvency

Liabilities / assets96.4%
Debt / equity12.70x
Current ratio1.53x
Interest coverage-0.50x

Cash quality & payout

Operating cash flow / net income0.50x
Accruals ratio-2.6%
Payout ratio—
Capex / revenue6.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: BRL FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31FY20202020-12-31
Income statement
Revenue77.41B70.57B96.52B105.62B58.54B
Cost of revenue71.41B67.55B85.16B73.57B47.33B
Gross profit6.00B3.02B11.36B32.06B11.21B
R&D expense463.00M383.00M374.00M297.00M250.65M
SG&A expense2.64B2.47B2.76B2.52B-4.08B
Operating income-1.08B-2.79B4.27B26.04B-71.89M
Interest expense6.85B5.59B5.07B4.90B4.91B
Pretax income-17.73B-6.19B47.00M17.96B-9.68B
Income tax-5.68B-1.30B868.00M4.00B-2.67B
Net income-11.32B-4.58B-336.00M13.98B-6.69B
EBITDA3.87B2.41B9.01B30.22B3.98B
EPS (basic)———17.57-8.41
EPS (diluted)———17.57-8.41
Balance sheet
Cash & equivalents14.99B14.19B12.47B8.68B13.86B
Short-term investments1.79B4.96B2.29B3.49B3.63B
Receivables3.56B2.91B3.23B7.15B4.73B
Inventory13.69B12.53B14.03B16.34B8.38B
Current assets37.04B37.44B34.46B39.29B34.19B
PP&E, netmay include right-of-use assets (IFRS)40.42B38.41B37.76B37.22B35.93B
Intangibles———2.88B2.83B
Total assets101.58B91.74B88.05B92.56B86.08B
Current liabilities28.27B24.49B24.19B25.19B28.39B
Short-term debt14.28B10.51B10.50B12.22B4.40B
Long-term debt50.95B40.21B34.33B33.55B40.41B
Total debt65.23B50.72B44.84B45.78B44.81B
Total liabilities105.85B88.46B3.01B4.19B89.95B
Shareholders' equity-4.78B3.99B7.32B7.87B-2.20B
Net debt50.24B36.53B32.37B37.10B30.95B
Shares outstanding797.21M797.21M797.21M797.21M797.22M
Cash flow statement
Operating cash flow2.44B-2.27B8.95B14.79B6.29B
Capital expenditure3.76B4.53B4.85B3.42B2.76B
Free cash flow-1.33B-6.80B4.10B11.37B3.53B
Investing cash flow-3.48B-4.53B-4.95B-3.38B-2.72B
Financing cash flow469.00M8.87B225.00M-16.97B2.17B
Depreciation & amortization4.95B5.21B4.73B4.18B4.05B
Dividends paid6.00M7.00M1.35B5.99B2.38M

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Amounts are in the company's reporting currency, BRL, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.